echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Cell host microbe: new research helps to develop malaria vaccine

    Cell host microbe: new research helps to develop malaria vaccine

    • Last Update: 2019-11-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    November 18, 2019 / BIOON / -- recently, Professor Denise Doolan and others of Australian Institute of tropical health and medicine (aithm) published an article, which narrowed the scope of vaccine and antibody development against severe malaria According to the latest data from the World Health Organization, there were 219 million malaria cases worldwide in 2017, with an estimated 435000 deaths "Due to the special survival strategy of malaria parasite in human body, it grows in blood cells and inserts proteins into the surface of blood cells to adhere to the blood vessel wall It makes the development of vaccines or therapeutic antibodies very difficult "Plasmodium can evade the immune response by changing the protein structure, and each strain has different protein composition, which makes it extremely difficult to identify vaccine targets." (image source: www Pixabay Com) a team of collaborators including the author collected hundreds of PfEMP1 proteins from hundreds of malaria strains from Australia By making custom protein microarrays of these strains and examining serum samples, we can determine which PfEMP1 variants are related to immune protection The project is an important step in developing a viable vaccine, said Alyssa Barry, associate professor at Deakin School of Medicine's infection systems epidemiology research group "For many years, researchers have considered it almost impossible to develop a malaria vaccine based on PfEMP1 because of its high diversity." "Using genome sequencing, we collected PfEMP1 proteins from different malaria strains, measured the antibodies to these proteins, and then used machine learning to identify the types of protective antibodies We were able to identify these antibodies by monitoring the type of disease, and then we tested them in children for 16 months to determine which of them were more susceptible to the more serious disease " Sources of information: scientists close in on malaria vaccine original sources: sofonias K tessema, RIE Nakajima, algis jasinskas, Stephanie L monk, lea lekieffre, emore Lin, Benson kiniboro, Carla Proietti, Peter Siba, Philip L felgner, Denise L Doolan, Ivo Mueller, Alyssa E Barry Protective Immunity against Severe Malaria in Children Is Associated with a Limited Repertoire of Antibodies to Conserved PfEMP1 Variants Cell Host & Microbe , 2019; 26 (5): 579 DOI: 10.1016/j.chom.2019.10.012
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.